Next is a Rev/low dose dex regimen scheduled to start in early September. The durability of which may be affected by the GRN163L therapy. Remember GRN is not an anti-tumor agent. It is an anti-MM stem cell agent. It is assumed the MM stem cell is a very small portion of the tumor burden. Only time will tell.
Wednesday, August 13, 2008
Sunday, August 10, 2008
I am over the hump and coasting toward a full recovery. The killer muscle tension I get from long periods of immobilization are irritating and screw around with that deep restful sleep I so long to experience. Complaining about such triviality after I step back and look at a slightly bigger picture makes me feel like a whiner. I have to admit whining is rewarding at times but it is sort of like shopping - the high is short lived.